Twin Tree Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Twin Tree Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.12M	Sell	10,300 -1,700	-14%	-$753K	0.1%	278
2026 Q1	$5.36M	Sell	12,000 -3,400	-22%	-$1.59M	0.11%	208
2025 Q4	$6.98M	Sell	15,400 -14,600	-49%	-$6.29M	0.06%	397
2025 Q3	$11.7M	Sell	30,000 -78,100	-72%	-$32.6M	0.05%	438
2025 Q2	$48.1M	Buy	+108,100	New	+$49.8M	0.09%	220
2025 Q1	–	Sell	-70,500	Closed	-$28.4M	–	1962
2024 Q4	$28.4M	Buy	70,500 +63,000	+840%	+$29.2M	0.05%	343
2024 Q3	$3.49M	Buy	+7,500	New	+$3.6M	0.01%	1011
2024 Q2	–	Sell	-27,700	Closed	-$11.6M	–	1679
2024 Q1	$11.6M	Sell	27,700 -65,900	-70%	-$27.9M	0.03%	596
2023 Q4	$38.1M	Buy	+93,600	New	+$34.6M	0.07%	270
2022 Q4	–	Sell	-1,900	Closed	-$550K	–	1560
2022 Q3	$550K	Buy	+1,900	New	+$547K	﹤0.01%	1117
2022 Q1	–	Sell	-100	Closed	-$22K	–	1939
2021 Q4	$22K	Buy	+100	New	+$19.4K	﹤0.01%	1505
2021 Q2	–	Sell	-700	Closed	-$150K	–	1633
2021 Q1	$150K	Hold	700	–	–	﹤0.01%	1159
2020 Q4	$165K	Sell	700 -146,700	-100%	-$33.7M	﹤0.01%	1115
2020 Q3	$40.1M	Buy	+147,400	New	+$40.7M	0.17%	133
2018 Q2	–	Sell	-4,200	Closed	-$685K	–	1365
2018 Q1	$685K	Sell	4,200 -500	-11%	-$81.7K	0.01%	739
2017 Q4	$704K	Buy	4,700 +3,900	+488%	+$577K	0.01%	764
2017 Q3	$122K	Buy	+800	New	+$120K	﹤0.01%	851
2014 Q4	–	Sell	-700	Closed	-$79K	–	1203
2014 Q3	$79K	Buy	+700	New	+$66.6K	﹤0.01%	908

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Twin Tree Management's VRTX Position: Q2 2026 in Review

Twin Tree Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 7,769 shares — an estimated $3.44M sold.

Twin Tree Management first reported a position in VRTX in Q3 2017 and held it in 26 quarters. The position peaked at $52.8M in Q4 2023. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Twin Tree Management reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Twin Tree Management sold 7,769 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.44M.
Twin Tree Management first reported a position in Vertex Pharmaceuticals in Q3 2017 and held it in 26 quarters.
Twin Tree Management's Vertex Pharmaceuticals position peaked at $52.8M in Q4 2023.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.